← All Sponsors
SPONSOR

NEC Bio B.V

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Triple Negative Breast Cancer
NCT06631092 Phase 1, Phase 2
Recruiting

Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer

Triple Negative Breast Cancer
Germany View Trial →